NCT07514767
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07514767
Title Evaluation of the Efficacy and Safety of Nivolumab Neoadjuvant Treatment of Patients With Locally Advanced Oral Squamous Cell Carcinoma (NOCANO)
Acronym NOCANO
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Prof. Lars Olaf Cardell
Indications
Therapies
Age Groups: adult | senior
Covered Countries SWE


No variant requirements are available.